In multiple myeloma, abnormal plasma cells build up inside bone marrow -- the spongy tissue inside large bones where blood cells are produced. Over time, myeloma cells cause damage to bones ...

The multiple myeloma armamentarium is large and getting larger. That makes treatment choices complex and the cost of ...

Treatment with cemsidomide resulted in notable responses at multiple dose levels for patients with multiple myeloma ...

Spinal cord pain isn't always just muscle strain — it could signal multiple myeloma. Learn the critical symptoms you must not ...

Michaela Hagenhofer, general manager, commercial operations at Johnson & Johnson Innovative Medicine, explains J&J’s ...

During a live event, Kathleen A. Dorritie, MD, discussed updated outcomes from the IsKia, MASTER, and CONCEPT clinical trials ...

Multiple myeloma can arise when plasma cells transform into malignant plasma cells which leads to the uncontrolled growth of these abnormal plasma cells.

Now, 181 years later, multiple myeloma remains incurable ... is not just based on a pathologist's interpretation of the bone marrow or blood tests, but requires quite a bit of physician judgment ...

A promising target for rare liver cancer, a functional cure for multiple myeloma — and support for people with ovarian cancer.

Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and a part of JSR Life ...

Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic products, today announced the availability of its first Laboratory Developed Test (LDT): GenoPredicta for ...